Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”

Bruce A.C. Cree, Benjamin Greenberg, Chris Cameron, Brian G. Weinshenker

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1439-1443
Number of pages5
JournalNeurology and Therapy
Volume11
Issue number3
DOIs
StateAccepted/In press - 2022

Keywords

  • Aquaporin-4
  • Eculizumab
  • Inebilizumab
  • Matching-adjusted indirect comparison
  • Network meta-analysis
  • Neuromyelitis optica spectrum disorder
  • Randomized controlled trials
  • Satralizumab

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this